Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents-Reference-Cited by-同舟云学术

Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents

Published:2019-10-18 Issue:2 Volume:23 Page:125-131
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Abraham Pranav¹,Kish Jonathan Karl²,Korytowsky Beata¹,Radtchenko Janna³,Singh Prianka¹,Shaw James¹,Feinberg Bruce²

Affiliation:

1. Bristol-Myers Squibb, Lawrence Township, NJ, USA;

2. Cardinal Health, Dublin, OH, USA;

3. Formerly of Cardinal Health, Dublin, OH, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1676760

Reference23 articles.

1. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

3. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Healthcare Resource Use Associated with Recurrent or Metastatic Head and Neck Cancer Patients Care in Portugal—TRACE Study;Current Oncology;2024-07-26

2. Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation;Cancers;2024-07-12

3. Trends in Cancer Treatment for Oral Cavity, Oropharynx, and Larynx in 2016 Versus 2009: SEER Patterns of Care Studies;Annals of Otology, Rhinology & Laryngology;2021-08-06